↓ Skip to main content

Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial

Overview of attention for article published in The Lancet, September 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
13 news outlets
blogs
6 blogs
policy
2 policy sources
twitter
52 tweeters
facebook
3 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
125 Dimensions

Readers on

mendeley
234 Mendeley
Title
Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial
Published in
The Lancet, September 2014
DOI 10.1016/s0140-6736(14)61231-9
Pubmed ID
Authors

Michael Sharpe, Jane Walker, Christian Holm Hansen, Paul Martin, Stefan Symeonides, Charlie Gourley, Lucy Wall, David Weller, Gordon Murray

Twitter Demographics

The data shown below were collected from the profiles of 52 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 234 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 4 2%
United States 2 <1%
Japan 1 <1%
Spain 1 <1%
Uruguay 1 <1%
Unknown 225 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 43 18%
Student > Ph. D. Student 34 15%
Student > Master 33 14%
Unspecified 27 12%
Student > Doctoral Student 23 10%
Other 74 32%
Readers by discipline Count As %
Medicine and Dentistry 76 32%
Psychology 54 23%
Unspecified 40 17%
Nursing and Health Professions 19 8%
Social Sciences 13 6%
Other 32 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 173. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2019.
All research outputs
#77,871
of 13,350,292 outputs
Outputs from The Lancet
#1,162
of 31,747 outputs
Outputs of similar age
#1,229
of 201,027 outputs
Outputs of similar age from The Lancet
#23
of 480 outputs
Altmetric has tracked 13,350,292 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,747 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 201,027 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 480 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.